Arabic Arabic English English French French German German
dark

Shoreline Launches into “Era of Cell Therapy” with $4 Billion in Partnerships

Shoreline Biosciences was propelled into the proverbial catbird’s seat this summer with two mega-deals, and now plans to double its employee base from 50 to 100 in the coming months. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

How Built-In Financial Services Can Help Healthcare Providers Rebound Post-Pandemic

Next Post

Happify Health & Higi Partnership to Create an AI-Driven Patient-Engagement Ecosystem that Makes Value-Based Healthcare Accessible Worldwide

Related Posts
Total
0
Share